Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (137) Arrow Down
Filter Results: (137) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (137)
    • News  (19)
    • Research  (110)
    • Events  (2)
    • Multimedia  (1)
  • Faculty Publications  (41)

Show Results For

  • All HBS Web  (137)
    • News  (19)
    • Research  (110)
    • Events  (2)
    • Multimedia  (1)
  • Faculty Publications  (41)
← Page 7 of 137 Results
  • 06 Jun 2017
  • First Look

First Look at New Research and Ideas: June 6, 2017

regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars market entrants,... View Details
Keywords: Sean Silverthorne
  • 12 Jan 2016
  • First Look

January 12, 2016

medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical practitioners, but with the widespread adoption of... View Details
Keywords: Carmen Nobel
  • 01 Feb 2011
  • First Look

First Look: Feb. 1

U.S. civil liability regime and cast at least partial limitations on the SEC's regulatory authority. This event nonetheless was met with positive abnormal returns of U.S.-listed foreign firms all over the world. These abnormal returns are... View Details
  • 12 Feb 2019
  • First Look

New Research and Ideas, February 12, 2019

collection and privacy. Finally, we discuss emerging challenges surrounding software-driven medical devices, including open regulatory questions, advancements in underlying digital technology, and the likely necessity of new payment and... View Details
Keywords: Dina Gerdeman
  • 07 Apr 2009
  • First Look

First Look: April 7, 2009

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=109057 Amylin Pharmaceuticals: Diabetes and Beyond Harvard Business School Case 809-011 Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's... View Details
Keywords: Martha Lagace
  • 19 Sep 2017
  • First Look

First Look at New Research and Ideas, September 19

consolidated into a single constraint. This helps to avoid a distortionary situation where different constraints bind for different banks performing the same activity. Second, while a regulatory framework that relies primarily on minimum... View Details
Keywords: Sean Silverthorne
  • 02 Oct 2015
  • News

The ‘F’ Word

equity, and sold the company. But the investors, including our family, lost money. Professionally, my judgment of aggregate risk was honed through this failure. The company was international, run out of a holding company with diluted control, and relied on a View Details
Keywords: Walt Disney Studios
  • 28 Oct 2014
  • First Look

First Look: October 28

exchange for taking on the risk of young companies in uncertain environments, venture capitalists receive board level oversight privileges, which range from approval of budgets and advice on product development to the right to replace the... View Details
Keywords: Carmen Nobel
  • 19 Jun 2007
  • First Look

First Look: June 19, 2007

addition, firms with more KLD concerns have slightly, but statistically significantly, more pollution and regulatory compliance violations in later years. KLD environmental strengths, in contrast, do not accurately predict pollution... View Details
Keywords: Martha Lagace
  • 10 Jul 2018
  • First Look

New Research and Ideas, July 10, 2018

seasonal cycles, enhance the appeal for investors in the exit, and improve the valuation. However, while Çavuşoğlu was laying out the plans for his next move with movie distribution in 2014, Turkey’s Council of State, the highest administrative court in the country,... View Details
Keywords: Dina Gerdeman
  • 01 Dec 2016
  • News

Alumni Books of 2016

and challenges facing the modern investor. It follows the rise of funded retirement, the evolution of investment vehicles and techniques, investment misdeeds and regulatory reform, government economic policy, the development of investment... View Details
  • 20 Jan 2017
  • Research & Ideas

Here’s How Businessman Trump Is Likely to Approach the Presidency

approval rating. That will require him to hone his communications skills and to win over many people who remain skeptical of his motives and competency. He must consciously set out to escape the Washington bubble and stay in touch with... View Details
Keywords: by Christina Pazzanese
  • Person Page

Media

Media

This lists media reports covering my firm dollarDEX Investments or me (or my colleagues), or columns written by me (or my colleagues). There are all... View Details

  • Web

Print View - Course Catalog

capture (NFT’s for example) and, most of all, moving the provision of trust from institutions and governments to network protocols that have no central authority. They challenge the core notions of brand value, scale, regulatory... View Details
  • ←
  • 7
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.